Vimovo

Vimovo is owned by Grünenthal Group, headquartered in Germany. No. The ultimate owner of Vimovo, Grünenthal Group, is headquartered in Germany, not in the United States.

Grünenthal is a global leader in pain management and related therapies, specializing in research-driven pharmaceutical products.

Vimovo is often distributed by Grünenthal Pharma or local licensed partners such as Horizon Therapeutics in the US.